Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triple Combination of Aliskiren/Valsartan/HCTZ in Hypertension
NCT00219193Phase 3Completed
- Sponsor
- Novartis
- Start
- Oct 2005
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of aliskiren in essential hypertension, sponsored by Novartis. Started Oct 2005; status: completed.
02
Drugs
aliskiren
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00219193.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00219193.